NIB finances Embla Medical’s R&D investments

• The Nordic Investment Bank (NIB) has signed a EUR 50 million investment loan with Iceland based Embla Medical to finance the company’s research and development (R&D) program.
• The loan has a term of seven years and supports Embla Medical’s mission to develop innovative medical solutions that enhance mobility and quality of life for people living with limb loss or mobility impairments.

Embla Medical’s R&D program focuses on developing cutting-edge technologies for people living with mobility impairment. Recently, the company has launched new innovations such as a fully waterproof bionic knee, and a mechanical foot offering improved flexibility, balance, and adaptability.

The company’s research efforts focus on the development of new products and the improvement of existing solutions. With this financing, Embla Medical will continue to further advance its portfolio, with the majority of R&D activity based in its head office in Reykjavik.

André Küüsvek, NIB President and CEO said: “At NIB, our commitment to financing a sustainable future and strengthening our societies aligns closely with Embla Medical’s mission to enhance quality of life through innovation. This investment supports cutting-edge research that benefits patients directly and speeds up the development of life-changing medical technologies.”

Embla Medical is a global provider of innovative mobility solutions that help people live a Life Without Limitations®. Founded as Össur in 1971, Embla Medical is now home to industry leading brands such as Össur, Fior & Gentz, College Park and ForMotion. The company’s head offices are in Reykjavik, Iceland, with extensive operations across the Americas, Europe, and Asia. Embla Medical is listed on Nasdaq Copenhagen under the ticker code EMBLA.

NIB is the international financial institution of Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Norway, and Sweden. The Bank finances projects that improve productivity and benefit the environment of the Nordic-Baltic region. The Bank is headquartered in Helsinki with a regional hub in Riga. NIB has the highest possible credit rating, AAA/Aaa, with S&P Global Ratings and Moody’s.

For further information, please contact

Stefan Fridriksson, Senior Banker, Country Lead Iceland, +358 50 311 1050, stefan.fridriksson@nib.int

Fridrik Andersen, Senior Banker, +358 10 618 0238, fridrik.andersen@nib.int

Iiris Anttalainen, Communications Officer, +358 10 618 0257, iiris.anttalainen@nib.int